A carregar...

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

Chronic hepatitis B virus (HBV) infection is prevalent, deadly, and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected cells. Newly developed genome engineering tools may offer the ability to directly cleave viral DNA, thereby promoting viral clearance. Here, we show that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Ramanan, Vyas, Shlomai, Amir, Cox, David B.T., Schwartz, Robert E., Michailidis, Eleftherios, Bhatta, Ankit, Scott, David A., Zhang, Feng, Rice, Charles M., Bhatia, Sangeeta N.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649911/
https://ncbi.nlm.nih.gov/pubmed/26035283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep10833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!